Martin Leon

Showing 1-20 of 41 articles

Interventions for valvular disease

Paravalvular Regurgitation Post-Transcatheter Aortic Valve Replacement in Intermediate Risk Patients: A Pooled PARTNER 2 Study

Chau KH, Chen S, Crowley A, Redfors B, Li D, Hahn R, Douglas PS, Alu MC, Finn MT, Kodali S, Jaber WA, Rodriguez L, Thourani VH, Pibarot P, Leon M

August 31, 2021 | 10.4244/EIJ-D-20-01293

Coronary interventions

Diagnostic performance of angiography-based fractional flow reserve by patient and lesion characteristics

Kobayashi Y, Collet C, Achenbach S, Engstrøm T, Assali A, Shlofmitz R, Fournier S, Kirtane A, Ali Z, Kornowski R, Leon M, De Bruyne B, Fearon W

July 20, 2021 | 10.4244/EIJ-D-19-00933

Outcomes of transcatheter tricuspid valve intervention by right ventricular function: a multicentre propensity-matched analysis

Schlotter F, Miura M, Kresoja K, Alushi B, Alessandrini H, Attinger-Toller A, Besler C, Biasco L, Braun D, Brochet E, Connelly K, de Bruijn S, Denti P, Estevez-Loureiro R, Fam N, Gavazzoni M, Himbert D, Ho E, Juliard J, Kalbacher D, Kaple R, Kreidel F, Latib A, Lubos E, Ludwig S, Mehr M, Monivas V, Nazif T, Nickenig G, Pedrazzini G, Pozzoli A, Praz F, Puri R, Rodés-Cabau J, Rommel K, Schäfer U, Schofer J, Sievert H, Tang G, Thiele H, Unterhuber M, Vahanian A, von Bardeleben R, von Roeder M, Webb J, Weber M, Wild M, Windecker S, Zuber M, Hausleiter J, Maisano F, Leon M, Hahn R, Lauten A, Taramasso M, Lurz P

July 20, 2021 | 10.4244/EIJ-D-21-00191

Coronary interventions

Drug-coated stents versus bare metal stents in Academic Research Consortium-defined high bleeding risk patients

Marquis-Gravel G, Urban P, Copt S, Capodanno D, Pocock S, Sadozai Slama S, Stoll H, Tanguay J, Mehran R, Leon M, Rao S, Morice M, Krucoff M

June 25, 2021 | 10.4244/EIJ-D-20-00749

Coronary interventions

Procedural characteristics and clinical outcomes in patients undergoing percutaneous coronary intervention for left main trifurcation disease: the EXCEL trial

Kandzari D, Gershlick A, Serruys P, Leon M, Morice M, Simonton C, Lembo N, Mansour S, Sabaté M, Sabik J, Kappetein A, Dressler O, Stone G

December 18, 2020 | 10.4244/EIJ-D-19-00686

Coronary interventions

Influence of final kissing balloon inflation on long-term outcomes after PCI of distal left main bifurcation lesions in the EXCEL trial

Kini A, Dangas G, Baber U, Vengrenyuk Y, Kandzari D, Leon M, Morice M, Serruys P, Kappetein A, Sabik J, Dressler O, Mehran R, Sharma S, Stone G

June 25, 2020 | 10.4244/EIJ-D-19-00851

Coronary interventions

The obesity paradox revisited: body mass index and long-term outcomes after PCI from a large pooled patient-level database

Wolny R, Maehara A, Liu Y, Zhang Z, Mintz GS, Redfors B, Madhavan M, Smits P, von Birgelen C, Serruys P, Mehran R, Leon M, Stone G

January 17, 2020 | 10.4244/EIJ-D-19-00467

Will the PARTNER 3 Low Risk Trial change my practice?

McConkey H, Modine T, Latib A, Jüni P, Windecker S, Leon M

December 20, 2019 | 10.4244/EIJ-D-19-00847

Reardon M, Leon M, Popma J, Mack M

November 15, 2019 | 10.4244/EIJV15I10A155

Interventions for heart failure

Pulmonary artery denervation using catheter-based ultrasonic energy

Rothman A, Jonas M, Castel D, Tzafriri A, Traxler H, Shav D, Leon M, Ben-Yehuda O, Rubin L

October 18, 2019 | 10.4244/EIJ-D-18-01082

Derivation and external validation of a novel risk score for prediction of 30-day mortality after percutaneous coronary intervention

Brener S, Leon M, Serruys P, Smits P, von Birgelen C, Mehran R, Kirtane A, Witzenbichler B, Rinaldi M, Metzger C, Mazzaferri E, Zhang Z, Stone G

August 9, 2019 | 10.4244/EIJ-D-19-00262

Interventions for valvular disease

Derivation and external validation of a simple risk tool to predict 30-day hospital readmissions after transcatheter aortic valve replacement

Khera S, Kolte D, Deo S, Kalra A, Gupta T, Abbott J, Kleiman N, Bhatt D, Fonarow G, Khalique O, Kodali S, Leon M, Elmariah S

June 20, 2019 | 10.4244/EIJ-D-18-00954

Coronary interventions

Radial versus femoral artery access in patients undergoing PCI for left main coronary artery disease: analysis from the EXCEL trial

Chen S, Redfors B, Liu Y, Ben-Yehuda O, Morice M, Leon M, Kandzari D, Mehran R, Lembo N, Banning A, Merkely B, Kappetein A, Sabik J, Serruys P, Stone G

November 20, 2018 | 10.4244/EIJ-D-18-00711

Interventions for valvular disease

Mortality risk after transcatheter aortic valve implantation: analysis of the predictive accuracy of the Transcatheter Valve Therapy registry risk assessment model

Codner P, Malick W, Kouz R, Patel A, Chen C-H, Terre J, Landes U, Vahl T, George I, Nazif T, Kirtane A, Khalique O, Hahn R, Leon M, Kodali S

July 20, 2018 | 10.4244/EIJ-D-18-00032

Interventions for valvular disease

Compare and contrast tricuspid and mitral valve anatomy: interventional perspectives for transcatheter tricuspid valve therapies

Taramasso M, Pozzoli A, Basso C, Thiene G, Denti P, Kuwata S, Nietlispach F, Alfieri O, Hahn R, Nickenig G, Schofer J, Leon M, Reisman M, Maisano F

March 20, 2018 | 10.4244/EIJ-D-17-00704

Novel radiation dose reduction fluoroscopic technology facilitates chronic total occlusion percutaneous coronary interventions

Balter S, Brinkman M, Kalra S, Nazif T, Parikh M, Kirtane A, Moses J, Leon M, Feri A, Green P, Ali Z, Liao M, Karmpaliotis D

December 8, 2017 | 10.4244/EIJ-D-16-00216

Interventions for valvular disease

Restorative valve therapy by endogenous tissue restoration: tomorrow’s world? Reflection on the EuroPCR 2017 session on endogenous tissue restoration

Serruys P, Miyazaki Y, Katsikis A, Abdelghani M, Leon M, Virmani R, Carrel T, Cox M, Onuma Y, Soliman O

September 24, 2017 | 10.4244/EIJ-D-17-00509

Coronary interventions

Outcomes of stenting extra-small (≤2.25 mm) vessels using the Resolute zotarolimus-eluting stent (R-ZES)

Parikh M, Soverow J, Leon M, Serruys P, Xu B, Yuan Z, Zambahari R, Kirtane A

November 20, 2016 | 10.4244/EIJV12I10A200

Coronary interventions

Design and rationale for a randomised comparison of everolimus-eluting stents and coronary artery bypass graft surgery in selected patients with left main coronary artery disease: the EXCEL trial

Kappetein A, Serruys P, Sabik J, Leon M, Taggart D, Morice M, Gersh B, Pocock S, Cohen D, Wallentin L, Ben-Yehuda O, Van Es G-A, Simonton C, Stone G

September 18, 2016 | 10.4244/EIJV12I7A141

Interventions for valvular disease

Upcoming TAVI trials: rationale, design and impact on clinical practice

Capodanno D, Leon M

September 18, 2016 | 10.4244/EIJV12SYA12

1
2
3

Latest news

Three-year TAVI outcomes for BAV vs TAV

FREE ARTICLE - Dao Zhou et al.

January 20, 2022

Percutaneous management of left ventricular assist device outflow graft obstruction

FREE ARTICLE - Aleksandra Gasecka et al.

January 19, 2022

EuroCTO Club Consensus on Dual Lumen Microcatheters for CTO Recanalisation; Predicting Radial Crossover in ACS, the MATRIX score; DAPT duration for BRS; and more…

December 17, 2021

Lipid-rich plaque density and LDL-C in statin-treated vs statin-naïve patients

FREE ARTICLE - Rebecca Torguson et al.

January 17, 2022

Redo transcatheter mitral valve replacement in mitral annular calcification

FREE ARTICLE - Jennifer Jdaidani et al

January 13, 2022

TAVI vs SAVR in bicuspid aortic valve stenosis

FREE ARTICLE - Monil Majmundar et al.

January 12, 2022

Management of MR patients undergoing TMVI screening

FREE ARTICLE - Sebastian Ludwig et al.

January 7, 2022

Valvular disease